# Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery

Study · id `cardio:ct-nct02527811` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02527811](<https://clinicaltrials.gov/study/NCT02527811>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02527811

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 450 participants.

## Technical summary

Registry record NCT02527811. Randomized; single masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2018-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 450 participants (planned count; ClinicalTrials.gov record NCT02527811, source copy `cardio:ctgov-nct02527811-2018-01-17`, retrieved 2026-10-26)
- Start date: 2015-04 (registry gives no type) (ClinicalTrials.gov record NCT02527811, source copy `cardio:ctgov-nct02527811-2018-01-17`, retrieved 2026-10-26)
- Primary completion: 2018-06 (anticipated) (ClinicalTrials.gov record NCT02527811, source copy `cardio:ctgov-nct02527811-2018-01-17`, retrieved 2026-10-26)
- Completion: 2018-12 (anticipated) (ClinicalTrials.gov record NCT02527811, source copy `cardio:ctgov-nct02527811-2018-01-17`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02527811, source copy `cardio:ctgov-nct02527811-2018-01-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02527811-2018-01-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery
- Condition: Congenital Heart Diseases
- Intervention (Drug): Ulinastatin
- Lead sponsor: Techpool Bio-Pharma Co., Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: Shanghai Children's Medical Center
- Collaborator class: OTHER
- Collaborator: Guangzhou Women and Children's Medical Center
- Collaborator class: OTHER
- Collaborator: Guangzhou General Hospital of Guangzhou Military Command
- Collaborator class: OTHER
- Collaborator: Nanjing Children's Hospital
- Collaborator class: OTHER
- Collaborator: Children's Hospital of Fudan University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)

## Provenance

Content hash: 119d3e6f132881902ba02783fe69cdfa3999db488b741d37fe0f27d759426451
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
